HOME >> BIOLOGY >> NEWS
Women's math performance affected by theories on sex differences: UBC researchers

Women perform differently on math tests depending on whether they believe math-related gender differences are determined by genetic or social differences, according to University of British Columbia researchers.

In a paper to be published in the Oct. 19 issue of Science magazine, UBC investigators Ilan Dar-Nimrod and Steven Heine explore how women's math performance is affected by stereotypes that link female underachievement to either genetic or experiential causes.

Women and math is a controversial topic that led to the 2006 resignation of Lawrence Summers, the former president of Harvard who speculated that one of the potential reasons why women are represented less in math and science professions is that fewer women than men have the intrinsic ability required by such jobs.

Dar-Nimrod and Heine's research suggests that women tend to perceive gender differences in math to be innate or genetic, but when women consider such differences to be based on theories of nurture rather than nature, they can improve their performance.

"Our study doesn't explore whether innate sex differences exist," says Dar-Nimrod, a Psychology doctoral student. "Instead, we investigated how the perceived source of stereotypes can influence women's math performance."

"The findings suggest that people tend to accept genetic explanations as if they're more powerful or irrevocable, which can lead to self-fulfilling prophecies," says Assoc. Prof. Heine, who teaches in the Dept. of Psychology.

"But experiential theories may allow a woman to say this stereotype doesn't apply to me," says Heine.

Between 2003 and 2006, Dar-Nimrod and Heine conducted their research with more than 220 female participants. Their study provided participants with bogus scientific explanations for alleged sex differences in math.

Some women received a genetic account of inborn traits to explain the difference while others received an experientia
'"/>

Contact: Lorraine Chan
lorraine.chan@ubc.ca
604-822-3213
University of British Columbia
19-Oct-2006


Page: 1 2

Related biology news :

1. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
2. Womens skin tone influences perception of beauty, health and age
3. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
4. Womens health findings presented at national conference
5. Womens bioethics project receives grant from Ford Foundation
6. 2006 SGO Annual Meeting on Womens Cancer
7. Womens health study finds vitamin E does not protect women from heart attack, stroke, or cancer
8. Womens health, tissue regeneration is focus of Illinois & Carle Hospital initiative
9. New research advances energy efficiency, safety and performance of public transit
10. Gene mutation linked to increased athletic performance in whippets
11. Individual differences in a clock gene predict decline of performance during sleep deprivation

Post Your Comments:
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:11/21/2014)... The report, "Synthetic Biology ... Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, ... Bioremediation) - Global Forecast to 2018", analyses ... opportunities, and challenges. , Browse 99 market ... 185 pages and in-depth TOC of the ...
(Date:11/21/2014)... Arkansas (PRWEB) November 20, 2014 ... Pinnacle Ozone Solutions, LLC (Pinnacle), and PCI, Inc., ... announced that they have been selected to provide ... of Fayetteville, Arkansas Paul R. Noland Wastewater Treatment. ... BlueInGreen’s patented HyDOZ® gas dissolution technology, ...
(Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... China Sodium Ferrocyanide Industry” is a professional and ... it provides Sodium ferrocyanide information, like its ... well as industry overview. This report covers the ... well as global (such as the US, Europe, ...
(Date:11/21/2014)... DIEGO , Nov. 20, 2014 ... has been dosed in its Phase 1 trial ... cisplatin for the treatment of malignant pleural mesothelioma ... Group is conducting clinical trials on ADI-PEG 20, ... agents, for the treatment of several other indications, ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
Cached News: